๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The epigenome as a molecular marker and target : Implications for cancer

โœ Scribed by David Gius; C. Matthew Bradbury; Lunching Sun; Rania T. Awwad; Lei Huang; Dee Dee K. Smart; Kheem S. Bisht; Allen S. Ho; Phuongmai Nguyen

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
238 KB
Volume
104
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Osteopontin as a molecular prognostic ma
Osteopontin as a molecular prognostic marker for melanoma
โœ Javier Rangel; Mehdi Nosrati; Sima Torabian; Ladan Shaikh; Stanley P. L. Leong; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 292 KB

## Abstract ## BACKGROUND. Osteopontin has been suggested as a marker of disease progression in patients with melanoma because of its overexpression in recent microarray analyses. However, its prognostic role in melanoma has not been fully defined. ## METHODS. Osteopontin expression status was e

DNA adducts as a marker for cancer risk?
DNA adducts as a marker for cancer risk?
โœ Kari Hemminki; Mikko Koskinen; Chunyan Zhao ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 35 KB
Wnt/ฮฒ-catenin-pathway as a molecular tar
Wnt/ฮฒ-catenin-pathway as a molecular target for future anti-cancer therapeutics
โœ Susanne Dihlmann; Magnus von Knebel Doeberitz ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 213 KB

Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit, regarding survival time not to mention cure of the patients. To improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Colorectal